H3 K27M (H3 K27-altered)

What it is

H3 K27M is a mutation in a histone H3 gene (histones are proteins that DNA wraps around). This mutation, or related changes ("H3 K27-altered"), defines diffuse midline glioma — a serious tumor that occurs mainly in children and is classified as WHO grade 4 regardless of how it looks under the microscope.

Understanding H3 K27M (H3 K27-altered)

The H3 K27M mutation changes a single building block in the histone protein, which broadly disrupts how genes are switched on and off (through effects on chemical "marks" on the histone). This drives the development of diffuse midline glioma, which arises in midline structures of the brain such as the brainstem (where it includes diffuse intrinsic pontine glioma, or DIPG), thalamus, and spinal cord. Because these tumors behave aggressively regardless of appearance, the 2021 classification designates them grade 4 whenever the H3 K27 alteration is present. They occur mainly in children and, unfortunately, carry a grave prognosis, which is why they are a major focus of research and clinical trials. These are difficult topics, and families facing them are supported by specialized teams. Understanding H3 K27M clarifies the mutation that defines this serious midline tumor.

Why it matters

Understanding H3 K27M helps families see the mutation that defines diffuse midline glioma — a serious grade 4 tumor of mainly children — and why its presence determines the grade regardless of appearance, guiding diagnosis and the search for new treatments.